KR880005920A - 인체의 백혈구 인터페론 조성물과 피부 치료법 - Google Patents
인체의 백혈구 인터페론 조성물과 피부 치료법 Download PDFInfo
- Publication number
- KR880005920A KR880005920A KR870012245A KR870012245A KR880005920A KR 880005920 A KR880005920 A KR 880005920A KR 870012245 A KR870012245 A KR 870012245A KR 870012245 A KR870012245 A KR 870012245A KR 880005920 A KR880005920 A KR 880005920A
- Authority
- KR
- South Korea
- Prior art keywords
- topical composition
- human body
- interferon
- skin
- effective amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (10)
- 연고형태의 부형제와 그 내부에 분산된 인체의 백혈구 인터페론을 유효양 함유하는 피부 치료용 국소 조성물.
- 제1항에 있어서, 침투 향상제를 포함하는 국소 조성물.
- 제1항에 있어서, 인체의 백혈구 인터페론이 조성물 그램당 약 150,000의 인터페론 국제 기준 유니트로 존재하는 것을 특징으로 하는 국소 조성물.
- 제2항에 있어서, 연화제를 유효양 함유하는 국소 조성물.
- 제4항에 있어서, 연화제가 카르복시메틸 셀룰로오즈인 것을 특징으로 하는 국소 조성물.
- 인체의 백혈구 인터페론을 분산상태로 함유하고 있는 부형제를 포함하는 국소 조성물을 감염 피부에 적용시켜 피부를 치료하는 방법.
- 인체의 백혈구 인터페론을 단순포진에 유효한 양만큼 함유하는 조성물을 피부의 감염 부위에 적용시켜 단순포진을 치료하는 방법.
- 인체의 백혈구 인터페론을 콘딜롬에 유효한 양만큼 함유하는 조성물을 피부의 감염 부위에 적용시켜 콘딜롬을 치료하는 방법.
- 인체의 백혈구 인터페론을 성병 우췌에 유효한 양만큼 함유하는 국소 조성물을 피부의 감염 부위에 적용하여 성병 우췌를 치료하는 방법.
- 친액성의 비독성 기제(base), 인체의 백혈구 인터페론 그리고 디메틸 술폭사이드 5중량%정도 그리고 카르복시메틸셀룰로오즈 0.5중량%정도 함유하는 피부 치료를 위한 화장품용 국소 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92845086A | 1986-11-10 | 1986-11-10 | |
US928,450 | 1986-11-10 | ||
US928450 | 1986-11-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880005920A true KR880005920A (ko) | 1988-07-21 |
KR960011231B1 KR960011231B1 (ko) | 1996-08-21 |
Family
ID=25456251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870012245A KR960011231B1 (ko) | 1986-11-10 | 1987-11-02 | 인체 백혈구 인터페론 및 침투 향상제를 함유하는 피부 병변 치료용 국소 조성물 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0267684B1 (ko) |
JP (1) | JP2681467B2 (ko) |
KR (1) | KR960011231B1 (ko) |
CA (1) | CA1321347C (ko) |
DE (1) | DE3750248T2 (ko) |
ES (1) | ES2061509T3 (ko) |
IL (1) | IL84080A0 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3803312A1 (de) * | 1988-02-04 | 1989-08-10 | Gerd Prof Dr Med Gross | Verwendung eines interferonenthaltenden gels |
WO1990000406A1 (en) * | 1988-07-05 | 1990-01-25 | Schering Corporation | Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon |
US4959210A (en) * | 1988-11-01 | 1990-09-25 | Schering Corporation | Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon |
US5882794A (en) * | 1994-09-30 | 1999-03-16 | E. I. Du Pont De Nemours And Company | Synthetic fiber cross-section |
US5723215A (en) * | 1994-09-30 | 1998-03-03 | E. I. Du Pont De Nemours And Company | Bicomponent polyester fibers |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3551554A (en) * | 1968-08-16 | 1970-12-29 | Crown Zellerbach Corp | Enhancing tissue penetration of physiologically active agents with dmso |
JPS5562024A (en) * | 1978-10-31 | 1980-05-10 | Hayashibara Takeshi | Preventive and remedy for interferon-sensitive disease |
EP0090837A1 (en) * | 1981-10-08 | 1983-10-12 | BERG, Kurt Frimann | Method and composition for treating a patient suffering from interferonsusceptible disorder |
CA1190148A (en) * | 1981-10-13 | 1985-07-09 | Samuel S. Asculai | Interferon-containing compositions |
DE3278234D1 (en) * | 1981-10-13 | 1988-04-21 | Exovir Inc | Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis |
US4435384A (en) * | 1982-04-30 | 1984-03-06 | Viragen, Inc. | Transfer factor composition and skin treatment |
US4605555A (en) * | 1984-09-20 | 1986-08-12 | Sun Star Kabushiki Kaisha | Composition and method for treating keratosic disorder of skin and mucosa |
-
1987
- 1987-09-30 CA CA000548227A patent/CA1321347C/en not_active Expired - Fee Related
- 1987-10-02 IL IL84080A patent/IL84080A0/xx unknown
- 1987-10-06 ES ES87308861T patent/ES2061509T3/es not_active Expired - Lifetime
- 1987-10-06 DE DE3750248T patent/DE3750248T2/de not_active Expired - Fee Related
- 1987-10-06 EP EP87308861A patent/EP0267684B1/en not_active Expired - Lifetime
- 1987-10-28 JP JP62270498A patent/JP2681467B2/ja not_active Expired - Fee Related
- 1987-11-02 KR KR1019870012245A patent/KR960011231B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0267684A2 (en) | 1988-05-18 |
JP2681467B2 (ja) | 1997-11-26 |
CA1321347C (en) | 1993-08-17 |
KR960011231B1 (ko) | 1996-08-21 |
DE3750248D1 (de) | 1994-08-25 |
DE3750248T2 (de) | 1995-03-16 |
JPS63130539A (ja) | 1988-06-02 |
ES2061509T3 (es) | 1994-12-16 |
EP0267684B1 (en) | 1994-07-20 |
IL84080A0 (en) | 1988-03-31 |
EP0267684A3 (en) | 1988-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4424232A (en) | Treatment of herpes simplex | |
ATE363283T1 (de) | Terfenadin-carboxylat und die behandlung von hautreizung | |
BE904421A (fr) | Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique. | |
NO891379D0 (no) | Anestetisk hudfuktingspreparat og fremgangsmaate for fremstilling derav. | |
UA41989C2 (uk) | Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри | |
DE69815122T2 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
SE9401406D0 (sv) | Pharmaceutical products for curing tumourous diseases and process for preparing same | |
KR960000855A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물 | |
US4678668A (en) | Method of reducing soft tissue swelling and pain | |
SE8703066D0 (sv) | Antiseptic composition containing ethyl alcohol and monolaurin | |
DK200201483A (da) | Dermatologisk anvendelse og dermatologisk præparat | |
FR2651434B1 (fr) | Composition d'acides desoxyribonucleiques depolymerises pour usage local dans les traitements cosmetiques de la peau et du corps. | |
KR880005920A (ko) | 인체의 백혈구 인터페론 조성물과 피부 치료법 | |
BR9708388A (pt) | Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação. | |
KR930019224A (ko) | 유산 위험 치료제 | |
KR960010003A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
KR880007068A (ko) | 13-시스 레티노산의 용도 | |
KR910002442A (ko) | 안구질환을 치료하는 방법 및 제약학적 조성물 | |
ATE86112T1 (de) | Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute. | |
KR920703060A (ko) | 제약학적 배합물 | |
KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
KR870010871A (ko) | 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법 | |
EP0397211A3 (en) | Percutaneous administration of 3'-azide-3'-deoxythymidine | |
CN1097990A (zh) | 一种治疗股癣的药物 | |
KR890001555A (ko) | 요산 배설용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020528 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |